Literature DB >> 9595418

Influence of endothelin-1 on clonidine-induced cardiovascular effects in anesthetized rabbits.

D Y Lim1, K Heo, C H Choi, E W Lee.   

Abstract

This study was designed to investigate the effect of endothelin-1 (ET-1) on clonidine-induced cardiovascular effects in urethane-anesthetized rabbits and to clarify the mechanism of its action. Clonidine (5, 10, and 20 micrograms/kg) given into a femoral vein (i.v.) produced a marked dose-dependent fall in arterial blood pressure and heart rate, but intracerebroventricular (i.c.v.) clonidine (2, 4, and 8 micrograms/kg) induced a slight depressor effect and bradycardia. Intravenous clonidine-induced hypotension was significantly enhanced by pretreatment with ET-1 or sarafotoxin, but the bradycardia was not affected. Intracerebroventricular clonidine-induced depressor responses were greatly inhibited by sarafotoxin pretreatment but not by ET-1. Both i.v. and i.c.v. ET-1 and sarafotoxin elicited marked hypotensive responses, with a slight decrease in heart rate. The depressor action evoked by i.v. ET-1 and sarafotoxin was significantly inhibited by nitroprusside but not by phentolamine or sodium acetylsalicylate. Furthermore, the weak bradycardia induced by ET-1 or sarafotoxin was not influenced by pretreatment with phentolamine, nitroprusside, or sodium acetylsalicylate. Taken together, these experimental data suggest that ET-1 potentiates clonidine-induced hypotensive responses in the urethane-anesthetized rabbit through facilitation of nitric oxide release, which appears to be associated with endothelin receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9595418     DOI: 10.1097/00005344-199800001-00037

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  1 in total

1.  Effect of Endothelin-1 on Baroreflexes and the Cardiovascular Action of Clonidine in Conscious Rabbits.

Authors:  Kyungjoon Lim; Maarten van den Buuse; Geoffrey A Head
Journal:  Front Physiol       Date:  2016-07-28       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.